Gardenia Carmen Gadelha Militão
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gardenia Carmen Gadelha Militão has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
Teresinha G. da Silva
Department of Antibiotics, Federal University of Pernambuco, Recife, Brazil
4 shared publications- Daniel Pereira Bezerra
Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil
3 shared publications - Paulo Michel Pinheiro Ferreira
Federal University of Piaui
3 shared publications - Teresinha Gonçalves da Silva
Department of Antibiotics, Federal University of Pernambuco (UFPE), Recife 50670-901, Brazil
3 shared publications - Claudia Pessoa
Universidade Federal do Ceará, Brasil
2 shared publications - Claudio Gabriel Lima-Junior
Departamento de Química, Universidade Federal da Paraíba-UFPB, João Pessoa-PB 58051-900, Brazil
2 shared publications
Latest Publications
- 16 June 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (10) , 1-10
A nontoxic N-hydrazinecarbothioamide β-lapachone (BV3) derivative acts as a sensitizer molecule to ionizing radiation on lung cancer cells
β-lapachone (β-Lap) and ionizing radiation kill cancer cells synergistically. Herein, we produced three thiosemicarbazone derivatives from β-Lap (BV2, BV3, and BV5) and treated lung cancer cells with BV compounds alone or in combination with gamma radiation; in addition, we assessed the acute toxicity of the compounds in Swiss mice. The NCI-H292 (lung cancer) cells were irradiated with 1 Gy gamma radiation dose with two protocols: 24 h before treatment with compounds or immediately after treatment with compounds. After radiation, cells were seeded in six-well plates, 24 h late compounds were added to the plate, and incubated for 24 h. After this period, the drug was removed. In another set of experiments, cells were treated with compounds at the half-maximal inhibitory concentration (IC50) concentration during 24 h, then the drug was removed and radiation was applied. Growth was monitored during 11 d. Acute Toxicity of Compounds was evaluated using OECD Guideline 423. Among three compounds tested at the survival clonogenic assay, only BV3 presented a lower IC50 (1.6 μg/mL) when associated with 1 Gy pre-gamma radiation, compared to non-irradiated BV3 treatment (2.8 μg/mL). When cells were first treated (24 h) with β-Lap derivatives at IC50 concentration and then irradiated with 1 Gy, a significant reduction on colony survival was observed for all compounds tested, BV2 (2.1 μg/mL), BV3 (2.8 μg/mL), or BV5 (1.9 μg/mL) resulting in 12%, 11%, 9% colony survival reduction, respectively. Regarding the toxicity, all Swiss mice survived to single pharmacological dose application (2000 mg/kg) of BV compounds. Compound BV3 showed the best radiosensitizing properties among the compounds tested, and no signs of irreversible tissue damage or death were observed when animals were exposed to a single high-dose.
- 16 June 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (10) , 1-10
A nontoxic N-hydrazinecarbothioamide β-lapachone (BV3) derivative acts as a sensitizer molecule to ionizing radiation on lung cancer cells
β-lapachone (β-Lap) and ionizing radiation kill cancer cells synergistically. Herein, we produced three thiosemicarbazone derivatives from β-Lap (BV2, BV3, and BV5) and treated lung cancer cells with BV compounds alone or in combination with gamma radiation; in addition, we assessed the acute toxicity of the compounds in Swiss mice. The NCI-H292 (lung cancer) cells were irradiated with 1 Gy gamma radiation dose with two protocols: 24 h before treatment with compounds or immediately after treatment with compounds. After radiation, cells were seeded in six-well plates, 24 h late compounds were added to the plate, and incubated for 24 h. After this period, the drug was removed. In another set of experiments, cells were treated with compounds at the half-maximal inhibitory concentration (IC50) concentration during 24 h, then the drug was removed and radiation was applied. Growth was monitored during 11 d. Acute Toxicity of Compounds was evaluated using OECD Guideline 423. Among three compounds tested at the survival clonogenic assay, only BV3 presented a lower IC50 (1.6 μg/mL) when associated with 1 Gy pre-gamma radiation, compared to non-irradiated BV3 treatment (2.8 μg/mL). When cells were first treated (24 h) with β-Lap derivatives at IC50 concentration and then irradiated with 1 Gy, a significant reduction on colony survival was observed for all compounds tested, BV2 (2.1 μg/mL), BV3 (2.8 μg/mL), or BV5 (1.9 μg/mL) resulting in 12%, 11%, 9% colony survival reduction, respectively. Regarding the toxicity, all Swiss mice survived to single pharmacological dose application (2000 mg/kg) of BV compounds. Compound BV3 showed the best radiosensitizing properties among the compounds tested, and no signs of irreversible tissue damage or death were observed when animals were exposed to a single high-dose.
- 19 November 2025
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 52 (1) , 461-480
Synthesis and evaluation of the cytotoxic activity in tumor cells of xanthene and tetraketone derivatives obtained via cascade reaction using chitosan as an organocatalyst
- 19 November 2025
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 52 (1) , 461-480
Synthesis and evaluation of the cytotoxic activity in tumor cells of xanthene and tetraketone derivatives obtained via cascade reaction using chitosan as an organocatalyst
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 57, e13258
Assessing the reaction to and efficacy of the Screener drug discovery and development board game as a pedagogical tool in postgraduate courses
Screener, a board game supplemented with online resources, was introduced and distributed by the Brazilian Society of Pharmacology and Experimental Therapeutics to postgraduate programs as an instructional tool for the process of drug discovery and development (DDD). In this study, we provided a comprehensive analysis of five critical aspects for evaluating the quality of educational games, namely: 1) description of the intervention; 2) underlying pedagogical theory; 3) identification of local educational gaps; 4) impact on diverse stakeholders; and 5) elucidation of iterative quality enhancement processes. We also present qualitative and quantitative assessments of the effectiveness of this game in 11 postgraduate courses. We employed the MEEGA+ online survey, comprising thirty-three close-ended unipolar items with 5-point Likert-type response scales, to assess student perceptions of the quality and utility of Screener. Based on 115 responses, the results indicated a highly positive outlook among students. In addition, we performed a preliminary evaluation of learning outcomes in two courses involving 28 students. Pre- and post-quizzes were applied, each consisting of 20 True/False questions directly aligned with the game's content. The analysis revealed significant improvement in students' performance following engagement with the game, with scores rising from 8.4 to 13.3 (Pt-test) and 9.7 to 12.7 (Pt-test). These findings underscore the utility of Screener as an enjoyable and effective tool for facilitating a positive learning experience in the DDD process. Notably, the game can also reduce the educational disparities across different regions of our continental country.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 57, e13258
Open AccessAssessing the reaction to and efficacy of the Screener drug discovery and development board game as a pedagogical tool in postgraduate courses
Screener, a board game supplemented with online resources, was introduced and distributed by the Brazilian Society of Pharmacology and Experimental Therapeutics to postgraduate programs as an instructional tool for the process of drug discovery and development (DDD). In this study, we provided a comprehensive analysis of five critical aspects for evaluating the quality of educational games, namely: 1) description of the intervention; 2) underlying pedagogical theory; 3) identification of local educational gaps; 4) impact on diverse stakeholders; and 5) elucidation of iterative quality enhancement processes. We also present qualitative and quantitative assessments of the effectiveness of this game in 11 postgraduate courses. We employed the MEEGA+ online survey, comprising thirty-three close-ended unipolar items with 5-point Likert-type response scales, to assess student perceptions of the quality and utility of Screener. Based on 115 responses, the results indicated a highly positive outlook among students. In addition, we performed a preliminary evaluation of learning outcomes in two courses involving 28 students. Pre- and post-quizzes were applied, each consisting of 20 True/False questions directly aligned with the game's content. The analysis revealed significant improvement in students' performance following engagement with the game, with scores rising from 8.4 to 13.3 (Pt-test) and 9.7 to 12.7 (Pt-test). These findings underscore the utility of Screener as an enjoyable and effective tool for facilitating a positive learning experience in the DDD process. Notably, the game can also reduce the educational disparities across different regions of our continental country.
- 1 January 2023
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 34 (9) , 1273-1283
Synthesis and Anticancer Activity of Homodimeric Morita-Baylis-Hillman Adducts Based on 3-Hydroxyindolin-2-one Core
Cancer treatment represents one of the main scientific study targets today, mainly due to the pronounced side effects arising from chemotherapy. This study reports the synthesis, characterization, and anticancer activity of ten compounds from the Morita-Baylis-Hillman reaction. Ethylene glycol diacrylate was used as a double Michael acceptor in reactions with isatin derivatives to give homodimers of 3-hydroxyindolin-2-one core, recognized in the literature for its extensive pharmacological profile. The use of 1,4-diazabicyclo[2,2,2]octane (DABCO) as a catalyst and room temperature were the optimal conditions for the study reaction. The isolated yields were up to 63%, with most reaction times inferior to 24 h, some as fast as 15 min. The anticancer potential of the synthesized dimers was evaluated in vitro against three cancer strains, resulting in average inhibitory concentrations up to 0.72 μM. It was also found that the best performing homodimers are more active than their monomeric counterparts. Considering the promising selectivity indices observed, the preliminary results obtained here act as a basis for broader tests regarding the effectiveness of homodimeric adducts against cancer cells.
- 1 January 2023
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 34 (9) , 1273-1283
Synthesis and Anticancer Activity of Homodimeric Morita-Baylis-Hillman Adducts Based on 3-Hydroxyindolin-2-one Core
Cancer treatment represents one of the main scientific study targets today, mainly due to the pronounced side effects arising from chemotherapy. This study reports the synthesis, characterization, and anticancer activity of ten compounds from the Morita-Baylis-Hillman reaction. Ethylene glycol diacrylate was used as a double Michael acceptor in reactions with isatin derivatives to give homodimers of 3-hydroxyindolin-2-one core, recognized in the literature for its extensive pharmacological profile. The use of 1,4-diazabicyclo[2,2,2]octane (DABCO) as a catalyst and room temperature were the optimal conditions for the study reaction. The isolated yields were up to 63%, with most reaction times inferior to 24 h, some as fast as 15 min. The anticancer potential of the synthesized dimers was evaluated in vitro against three cancer strains, resulting in average inhibitory concentrations up to 0.72 μM. It was also found that the best performing homodimers are more active than their monomeric counterparts. Considering the promising selectivity indices observed, the preliminary results obtained here act as a basis for broader tests regarding the effectiveness of homodimeric adducts against cancer cells.
- 5 August 2022
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 365, 110057
Anticancer activity of β-Lapachone derivatives on human leukemic cell lines
- 5 August 2022
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 365, 110057
Anticancer activity of β-Lapachone derivatives on human leukemic cell lines
- 27 July 2022
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 89 (03) , 286-294
Natural Dibenzo[b,f]oxepines, Pacharin and Bauhiniastatin-1, Isolated from Bauhinia acuruana Induce Apoptosis on Breast Cancer Cells via MCL-1 Protein Reduction
Herein, we describe the antiproliferative effects of two natural dibenzo [b,f]oxepines, pacharin and bauhiniastatin-1, isolated from Bauhinia acuruana on a breast cancer cell line and the mode of action underlying the cytotoxicity. Both compounds were cytotoxic in a panel of six tumor lines analyzed by the MTT assay, and IC50 values ranged from 7.8 to 45.1 µM, including human breast adenocarcinoma (MCF-7) cells. In contrast, none of the compounds were cytotoxic on normal human peripheral blood mononuclear cells (IC50 > 100 µM). Human breast adenocarcinoma (MCF-7) cells treated with pacharin or bauhiniastatin-1 20 µM for 24 h presented a reduction in cell volume and intensification of chromatin condensation, DNA fragmentation, and apoptotic cells. These findings became more evident after 48 h of exposure. Antiapoptotic B-cell lymphoma-2 family members, such as myeloid cell leukemia-1 and B-cell lymphoma-extra large, are important targets in cancer cells since their overexpression confers resistance to cancer treatments. A significant reduction of the myeloid cell leukemia-1 protein levels in human breast adenocarcinoma (MCF-7) cells after 24 h of treatment with pacharin or bauhiniastatin-1 at 20 µM was observed, while the B-cell lymphoma-extra large protein content was reduced in bauhiniastatin-1-treated cells at 40 µM only. The cytotoxic effects of pacharin and bauhiniastatin-1 are likely linked to myeloid cell leukemia-1 inhibition, which leads to the apoptosis of breast adenocarcinoma cells. Received: 04 March 2022 Accepted after revision: 27 July 2022 Accepted Manuscript online: 27 July 2022 Article published online: 23 August 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 27 July 2022
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 89 (03) , 286-294
Natural Dibenzo[b,f]oxepines, Pacharin and Bauhiniastatin-1, Isolated from Bauhinia acuruana Induce Apoptosis on Breast Cancer Cells via MCL-1 Protein Reduction
Herein, we describe the antiproliferative effects of two natural dibenzo [b,f]oxepines, pacharin and bauhiniastatin-1, isolated from Bauhinia acuruana on a breast cancer cell line and the mode of action underlying the cytotoxicity. Both compounds were cytotoxic in a panel of six tumor lines analyzed by the MTT assay, and IC50 values ranged from 7.8 to 45.1 µM, including human breast adenocarcinoma (MCF-7) cells. In contrast, none of the compounds were cytotoxic on normal human peripheral blood mononuclear cells (IC50 > 100 µM). Human breast adenocarcinoma (MCF-7) cells treated with pacharin or bauhiniastatin-1 20 µM for 24 h presented a reduction in cell volume and intensification of chromatin condensation, DNA fragmentation, and apoptotic cells. These findings became more evident after 48 h of exposure. Antiapoptotic B-cell lymphoma-2 family members, such as myeloid cell leukemia-1 and B-cell lymphoma-extra large, are important targets in cancer cells since their overexpression confers resistance to cancer treatments. A significant reduction of the myeloid cell leukemia-1 protein levels in human breast adenocarcinoma (MCF-7) cells after 24 h of treatment with pacharin or bauhiniastatin-1 at 20 µM was observed, while the B-cell lymphoma-extra large protein content was reduced in bauhiniastatin-1-treated cells at 40 µM only. The cytotoxic effects of pacharin and bauhiniastatin-1 are likely linked to myeloid cell leukemia-1 inhibition, which leads to the apoptosis of breast adenocarcinoma cells. Received: 04 March 2022 Accepted after revision: 27 July 2022 Accepted Manuscript online: 27 July 2022 Article published online: 23 August 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 14 December 2021
- Published by Universidade Federal de Pernambuco in Estudos Universitários
- Vol. 38 (2) , 379-400
Desafios e conquistas da implementação do diagnóstico molecular da Covid-19 na Universidade Federal de Pernambuco
A ampla testagem da população é uma das formas mais eficazes para o controle da disseminação da Covid-19. Portanto, a Universidade Federal de Pernambuco (UFPE), em parceria com outras instituições públicas, forneceu infraestrutura e prestação de serviço para a realização dos exames moleculares do novo coronavírus, ampliando a testagem na população no estado de Pernambuco. Este artigo relata a experiência da UFPE no processo de implementação do teste molecular para a detecção de Covid-19. Para a implementação, foram necessárias articulações conjuntas entre o Gabinete do Reitor da UFPE, a Pró-Reitoria de Pesquisa e Inovação, a Superintendência de Infraestrutura da UFPE, a Fundação de Apoio ao Desenvolvimento da UFPE e professores de diferentes departamentos da universidade. O laboratório foi estruturado conforme as normas e diretrizes da Resolução da Diretoria Colegiada/Agência Nacional de Vigilância Sanitária. Termocicladores para RT-qPCR, ultra freezers e demais insumos foram cotados e adquiridos em um curto espaço de tempo, levando-se em conta as dificuldades de compra e importação de produtos. Após capacitações, implementação da gestão da qualidade e testes de proficiência com certificação, o laboratório iniciou a testagem. Em pouco menos de um ano, a UFPE entregou 89 mil laudos do diagnóstico molecular da Covid-19. Durante o processo de implementação, a urgência para a adequação estrutural e o atraso da chegada dos insumos foram as maiores dificuldades encontradas. A cooperação entre a UFPE, o estado de Pernambuco e as instituições ministeriais federais para a estruturação de um laboratório de apoio para o diagnóstico da Covid-19 pode ser seguida como modelo, pois mostrou-se efetiva considerando o número de testes realizados com confiabilidade, no curto período transcorrido, para dar suporte em tempo hábil aos gestores públicos na tomada de decisões frente à pandemia.
- 14 December 2021
- Published by Universidade Federal de Pernambuco in Estudos Universitários
- Vol. 38 (2) , 379-400
Open AccessDesafios e conquistas da implementação do diagnóstico molecular da Covid-19 na Universidade Federal de Pernambuco
A ampla testagem da população é uma das formas mais eficazes para o controle da disseminação da Covid-19. Portanto, a Universidade Federal de Pernambuco (UFPE), em parceria com outras instituições públicas, forneceu infraestrutura e prestação de serviço para a realização dos exames moleculares do novo coronavírus, ampliando a testagem na população no estado de Pernambuco. Este artigo relata a experiência da UFPE no processo de implementação do teste molecular para a detecção de Covid-19. Para a implementação, foram necessárias articulações conjuntas entre o Gabinete do Reitor da UFPE, a Pró-Reitoria de Pesquisa e Inovação, a Superintendência de Infraestrutura da UFPE, a Fundação de Apoio ao Desenvolvimento da UFPE e professores de diferentes departamentos da universidade. O laboratório foi estruturado conforme as normas e diretrizes da Resolução da Diretoria Colegiada/Agência Nacional de Vigilância Sanitária. Termocicladores para RT-qPCR, ultra freezers e demais insumos foram cotados e adquiridos em um curto espaço de tempo, levando-se em conta as dificuldades de compra e importação de produtos. Após capacitações, implementação da gestão da qualidade e testes de proficiência com certificação, o laboratório iniciou a testagem. Em pouco menos de um ano, a UFPE entregou 89 mil laudos do diagnóstico molecular da Covid-19. Durante o processo de implementação, a urgência para a adequação estrutural e o atraso da chegada dos insumos foram as maiores dificuldades encontradas. A cooperação entre a UFPE, o estado de Pernambuco e as instituições ministeriais federais para a estruturação de um laboratório de apoio para o diagnóstico da Covid-19 pode ser seguida como modelo, pois mostrou-se efetiva considerando o número de testes realizados com confiabilidade, no curto período transcorrido, para dar suporte em tempo hábil aos gestores públicos na tomada de decisões frente à pandemia.
- Open Access
- 3 September 2021
- Published by Wiley in Journal of Oncology
- Vol. 2021, 1-18
Aminoquinolines as Translational Models for Drug Repurposing: Anticancer Adjuvant Properties and Toxicokinetic-Related Features
The indiscriminate consumption of antimalarials against coronavirus disease-2019 emphasizes the longstanding clinical weapons of medicines. In this work, we conducted a review on the antitumor mechanisms of aminoquinolines, focusing on the responses and differences of tumor histological tissues and toxicity related to pharmacokinetics. This well-defined analysis shows similar mechanistic forms triggered by aminoquinolines in different histological tumor tissues and under coexposure conditions, although different pharmacological potencies also occur. These molecules are lysosomotropic amines that increase the antiproliferative action of chemotherapeutic agents, mainly by cell cycle arrest, histone acetylation, physiological changes in tyrosine kinase metabolism, inhibition of PI3K/Akt/mTOR pathways, cyclin D1, E2F1, angiogenesis, ribosome biogenesis, triggering of ATM-ATR/p53/p21 signaling, apoptosis, and presentation of tumor peptides. Their chemo/radiotherapy sensitization effects may be an adjuvant option against solid tumors, since 4-aminoquinolines induce lysosomal-mediated programmed cytotoxicity of cancer cells and accumulation of key markers, predominantly, LAMP1, p62/SQSTM1, LC3 members, GAPDH, beclin-1/Atg6, α-synuclein, and granules of lipofuscin. Adverse effects are dose-dependent, though most common with chloroquine, hydroxychloroquine, amodiaquine, and other aminoquinolines are gastrointestinal changes, blurred vision ventricular arrhythmias, cardiac arrest, QTc prolongation, severe hypoglycemia with loss of consciousness, and retinopathy, and they are more common with chloroquine than with hydroxychloroquine and amodiaquine due to pharmacokinetic features. Additionally, psychological/neurological effects were also detected during acute or chronic use, but aminoquinolines do not cross the placenta easily and low quantity is found in breast milk despite their long mean residence times, which depends on the coexistence of hepatic diseases (cancer-related or not), first pass metabolism, and comedications. The low cost and availability on the world market have converted aminoquinolines into star drugs for pharmaceutical repurposing, but a continuous pharmacovigilance is necessary because these antimalarials have multiple modes of action/unwanted targets, relatively narrow therapeutic windows, recurrent adverse effects, and related poisoning self-treatment. Therefore, their use must obey strict rules, ethical and medical prescriptions, and clinical and laboratory monitoring.
- 3 September 2021
- Published by Wiley in Journal of Oncology
- Vol. 2021, 1-18
Open AccessAminoquinolines as Translational Models for Drug Repurposing: Anticancer Adjuvant Properties and Toxicokinetic-Related Features
The indiscriminate consumption of antimalarials against coronavirus disease-2019 emphasizes the longstanding clinical weapons of medicines. In this work, we conducted a review on the antitumor mechanisms of aminoquinolines, focusing on the responses and differences of tumor histological tissues and toxicity related to pharmacokinetics. This well-defined analysis shows similar mechanistic forms triggered by aminoquinolines in different histological tumor tissues and under coexposure conditions, although different pharmacological potencies also occur. These molecules are lysosomotropic amines that increase the antiproliferative action of chemotherapeutic agents, mainly by cell cycle arrest, histone acetylation, physiological changes in tyrosine kinase metabolism, inhibition of PI3K/Akt/mTOR pathways, cyclin D1, E2F1, angiogenesis, ribosome biogenesis, triggering of ATM-ATR/p53/p21 signaling, apoptosis, and presentation of tumor peptides. Their chemo/radiotherapy sensitization effects may be an adjuvant option against solid tumors, since 4-aminoquinolines induce lysosomal-mediated programmed cytotoxicity of cancer cells and accumulation of key markers, predominantly, LAMP1, p62/SQSTM1, LC3 members, GAPDH, beclin-1/Atg6, α-synuclein, and granules of lipofuscin. Adverse effects are dose-dependent, though most common with chloroquine, hydroxychloroquine, amodiaquine, and other aminoquinolines are gastrointestinal changes, blurred vision ventricular arrhythmias, cardiac arrest, QTc prolongation, severe hypoglycemia with loss of consciousness, and retinopathy, and they are more common with chloroquine than with hydroxychloroquine and amodiaquine due to pharmacokinetic features. Additionally, psychological/neurological effects were also detected during acute or chronic use, but aminoquinolines do not cross the placenta easily and low quantity is found in breast milk despite their long mean residence times, which depends on the coexistence of hepatic diseases (cancer-related or not), first pass metabolism, and comedications. The low cost and availability on the world market have converted aminoquinolines into star drugs for pharmaceutical repurposing, but a continuous pharmacovigilance is necessary because these antimalarials have multiple modes of action/unwanted targets, relatively narrow therapeutic windows, recurrent adverse effects, and related poisoning self-treatment. Therefore, their use must obey strict rules, ethical and medical prescriptions, and clinical and laboratory monitoring.